CD33KO-HSPC Infusion Followed by CART-33 Infusion(s) for Refractory/Relapsed AML

Clinical trial NCT05945849 · RECRUITING

Trial details

NCT number: NCT05945849
Sponsor: University of Pennsylvania
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Leukemia, Myeloid, Acute

Start date: 2024-02-23
Primary completion: 2029-02-23
Enrollment: 16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.